PARP inhibitors in newly diagnosed or recurrent ovarian cancer maintenance therapy: evidence of efficacy and safety from randomized controlled trials
Article in Biomedical Research and Therapy (December 2023)
The most recent citing publications are shown below. View all 67 publications that cite this research output on Dimensions.
Article in Biomedical Research and Therapy (December 2023)
Article in PLOS ONE (November 2023)
Article in Oncology Letters (September 2023)